General Information of Drug Off-Target (DOT) (ID: OTOFJLFA)

DOT Name Calmodulin-like protein 5 (CALML5)
Synonyms Calmodulin-like skin protein
Gene Name CALML5
Related Disease
Alzheimer disease ( )
Psoriasis ( )
Skin disease ( )
UniProt ID
CALL5_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2B1U
Pfam ID
PF13499
Sequence
MAGELTPEEEAQYKKAFSAVDTDGNGTINAQELGAALKATGKNLSEAQLRKLISEVDSDG
DGEISFQEFLTAAKKARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELD
AMIREADVDQDGRVNYEEFARMLAQE
Function Binds calcium. May be involved in terminal differentiation of keratinocytes.
Tissue Specificity Particularly abundant in the epidermis where its expression is directly related to keratinocyte differentiation. Very low expression in lung.
KEGG Pathway
Ras sig.ling pathway (hsa04014 )
Rap1 sig.ling pathway (hsa04015 )
Calcium sig.ling pathway (hsa04020 )
cGMP-PKG sig.ling pathway (hsa04022 )
cAMP sig.ling pathway (hsa04024 )
Phosphatidylinositol sig.ling system (hsa04070 )
Oocyte meiosis (hsa04114 )
Cellular senescence (hsa04218 )
Adrenergic sig.ling in cardiomyocytes (hsa04261 )
Vascular smooth muscle contraction (hsa04270 )
Apelin sig.ling pathway (hsa04371 )
C-type lectin receptor sig.ling pathway (hsa04625 )
Circadian entrainment (hsa04713 )
Long-term potentiation (hsa04720 )
Neurotrophin sig.ling pathway (hsa04722 )
Dopaminergic sy.pse (hsa04728 )
Olfactory transduction (hsa04740 )
Phototransduction (hsa04744 )
Inflammatory mediator regulation of TRP channels (hsa04750 )
Insulin sig.ling pathway (hsa04910 )
GnRH sig.ling pathway (hsa04912 )
Estrogen sig.ling pathway (hsa04915 )
Melanogenesis (hsa04916 )
Oxytocin sig.ling pathway (hsa04921 )
Glucagon sig.ling pathway (hsa04922 )
Renin secretion (hsa04924 )
Aldosterone synthesis and secretion (hsa04925 )
Salivary secretion (hsa04970 )
Gastric acid secretion (hsa04971 )
Alzheimer disease (hsa05010 )
Parkinson disease (hsa05012 )
Pathways of neurodegeneration - multiple diseases (hsa05022 )
Amphetamine addiction (hsa05031 )
Alcoholism (hsa05034 )
Pertussis (hsa05133 )
Tuberculosis (hsa05152 )
Human cytomegalovirus infection (hsa05163 )
Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
Human immunodeficiency virus 1 infection (hsa05170 )
Pathways in cancer (hsa05200 )
Glioma (hsa05214 )
Lipid and atherosclerosis (hsa05417 )
Fluid shear stress and atherosclerosis (hsa05418 )
Reactome Pathway
Neutrophil degranulation (R-HSA-6798695 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Alzheimer disease DISF8S70 Strong Biomarker [1]
Psoriasis DIS59VMN Strong Biomarker [2]
Skin disease DISDW8R6 Strong Biomarker [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Calmodulin-like protein 5 (CALML5). [3]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Calmodulin-like protein 5 (CALML5). [6]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Calmodulin-like protein 5 (CALML5). [4]
Acocantherin DM7JT24 Approved Acocantherin affects the expression of Calmodulin-like protein 5 (CALML5). [5]
------------------------------------------------------------------------------------

References

1 Calmodulin-like skin protein suppresses the increase in senescence-associated -galactosidase induced by hydrogen peroxide or ultraviolet irradiation in keratinocytes.Cell Biol Int. 2019 Jul;43(7):835-843. doi: 10.1002/cbin.11159. Epub 2019 May 18.
2 Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis.Exp Dermatol. 2006 Jun;15(6):469-77. doi: 10.1111/j.1600-0625.2006.00433.x.
3 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
4 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
5 Proteomics analysis of the proliferative effect of low-dose ouabain on human endothelial cells. Biol Pharm Bull. 2007 Feb;30(2):247-53. doi: 10.1248/bpb.30.247.
6 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.